Today’s AI Top Pick: MORN
7/27/2026 · Low Float Bullish Consensus Deep Rotation screen · a free sample of K3vl4r’s AI-curated picks.
AI-ranked from a screened shortlist, with entry strategy, targets, and risks.
View the live MORN price forecast →
MORN is the cleanest confluence trade in this pool: it has the highest fundamental_score (8) alongside the only 4-timeframe fully aligned bullish setup with near_term_bullish = 1.0 and bullish_prob = 1.0. Every timeframe forecast is positive across short/mid/long horizons — 1h (+5.47/+6.8/−0.15%), 4h (+2.19/+4.66/+6.58%), 1d (+10.23/+15.01/+23.08%), and 1wk (+9.62/+31.33/+46.39%). No other name in the pool shows this level of directional agreement without a red flag. Fundamentals back the tape: PE 17.59, fwdPe 12.83, PEG 0.74, ROE 30.66%, operMargin 22.52%, salesYoY +8.39%, instOwn 62.94%, recom 1.67, targetUpsidePct +30.9%. This is a real business (Morningstar) trading at a reasonable multiple with a −20.57% YTD / −37.99% 1yr drawdown that has already washed out weak hands — the weekly chart still sits at only 60.64% of its 21-bar range with −6.80% dd from high, so despite the 1h/4h pushing 100% of range, the higher-timeframe context is not extended. That is the rare combination of near-term momentum with structural room to run. Why TODAY vs. waiting: the daily forecast (fc_short +10.23%, fc_long +23.08%) is meaningfully above the intraday extension risk, and the weekly is only 60% up its range with a +46% long-horizon forecast — waiting for a pullback risks missing a re-rating that the multi-timeframe model is pricing in now. Compare to alternatives that superficially look strong: HURN reports earnings this week (binary event risk), DCBO's near-term forecasts are flat-to-negative despite the buyback (BUY_PULLBACK), TASK has a Wedbush note on a top-client exit that undercuts the +30/+54/+34 forecast stack, and CCB just lost its CFO with stock trading lower on the news. MORN has no comparable headline landmine — the only recent piece is a valuation take from Simply Wall St. and neutral PitchBook/Lumonic product news. Bottom line: strongest fundamentals + cleanest MTF confirmation + no negative catalyst = the highest-conviction buy in the book today.
- Extended intraday: pos_in_21bar_range_pct = 100% on both 1h and 4h with 0% drawdown — a same-day mean-reversion of 1–2% is plausible; scale in rather than chasing.
- 1h fc_long is slightly negative (−0.15%) suggesting a very short-term stall before the daily/weekly trend resumes.
- debtEq is elevated at 1.87 — refinancing sensitivity if rates back up.
- Financial-sector correlation risk: MORN trades with capital markets sentiment; a broad tape drawdown drags it independent of fundamentals.
- Analyst recom is 1.67 (moderate buy, not strong buy) and targetUpsidePct is only +30.9% — less asymmetric than small-cap names in this pool if the multi-timeframe forecast doesn't play out.
| # | Symbol | Verdict | Score | Read |
|---|---|---|---|---|
| 1 | MORN | BUY NOW | 8.6 | Only name with 4-TF alignment, near_term=1.0, fundamental_score=8, and no negative headline. |
| 2 | DCBO | BUY PULLBACK | 7.4 | Excellent fundamentals + $70M SIB catalyst, but short-term forecasts flat — buy the dip toward $18.50. |
| 3 | TASK | BUY PULLBACK | 7.1 | Cheap (fwdPe 3.59) with strong MTF forecasts, but at 100% range and Wedbush client-exit note is a live overhang. |
| 4 | HURN | WAIT | 6.6 | Strong fundamentals and 1d fc +12/+28/+24%, but earnings this week is binary; revisit after print. |
| 5 | BESS | BUY PULLBACK | 6.4 | Deep drawdown (-39.8% 1d) with 1d mid +107% and 1wk long +122% forecasts plus positive FPUSA project news; size small. |
| 6 | CSV | BUY PULLBACK | 6.2 | Solid fundamentals (PE 14, ROE 17.76) and near_term=1.0, but StockStory 'sell' note and modest forecast magnitudes limit upside. |
| 7 | USLM | WAIT | 5.9 | All 4 TFs at 100% range with weekly forecasts turning negative (−22/−39%) — extended, wait for pullback. |
| 8 | IDN | BUY PULLBACK | 5.7 | Big 1h/4h/1d forecasts (+35/+50/+43%) at 0% range but weekly forecasts negative and RSI 29.69 — knife-catch. |
| 9 | TNXP | BUY PULLBACK | 5.6 | Real Medicare/TONMYA catalyst expanding to 145M lives; deep pullback (-24% 21bar) with fc_long +90% on daily. |
| 10 | GLMD | BUY PULLBACK | 5.5 | Positive Aramchol cardiac formulation catalyst + patent notice; all TFs at 0% range with 1d fc_long +144%. |
| 11 | EVGN | BUY PULLBACK | 5.4 | PCSK9 partnership catalyst, 1d fc +85/+85/+86% and 1wk long +412%, but fundamentals ugly (operMargin -757%). |
| 12 | AKTX | WAIT | 5.2 | Maxim $30 upgrade + Whitehawk collab, but 1h fc_long -45% and weekly fc -100% are contradictory signals. |
| 13 | IDR | AVOID | 5.1 | Weekly fc_long -79.86% and fc_mid -55.96% break the multi-TF thesis despite strong fundamentals. |
| 14 | RGNT | BUY PULLBACK | 5.0 | Two positive patent/regulatory catalysts; -48% drop leaves pos=0% with 1d fc +14/+33/+56%. |
| 15 | MBRX | WAIT | 4.7 | MIRACLE trial data missed significance on 6/30 (-25%); positive follow-up spin doesn't clear the miss. |
| 16 | BCDA | BUY PULLBACK | 4.7 | FDA supportive path catalyst from 6/5; 1wk fc +158/+164/+265% but SalesYoY -100% is a fundamental hole. |
| 17 | DRMA | BUY PULLBACK | 4.5 | 1d fc +30/+82/+185% with near_term=1.0 but tiny $5.3M cap and no clear catalyst. |
| 18 | XTLB | WAIT | 4.4 | Only name with positive perfYtd (+26.72%) but 1h/4h forecasts negative — momentum stalling. |
| 19 | QNTM | WAIT | 4.3 | 1h fc +84/+92/+73% but weekly fc_short -60.45% conflict; ROE -984% is broken. |
| 20 | TGEN | WAIT | 4.2 | 1d fc +73/+69/+38% and $3.3M orders, but weekly fc negative (-9.88/-35.78/-46.78%) — split signal. |
| 21 | SHOE | WAIT | 4.1 | PEG 5.09, recom 2.33 (weak), shortFloat 23.65%, and only 2 TFs with modest forecasts. |
| 22 | WW | AVOID | 4.0 | Only 1d TF available, salesYoY -9.61%, near_term_bullish null — insufficient signal. |
| 23 | INTZ | WAIT | 3.9 | Investor day momentum but stock 'sinks as market gains' per Zacks; operMargin -171% is broken. |
| 24 | YCBD | WAIT | 3.8 | Near_term=0.2 and all pos_in_range=0 with modest forecasts; $5.6M micro-cap. |
| 25 | LUCY | AVOID | 3.6 | Warrant exercise dilution on 7/8 ($3M gross proceeds) undercuts the Claude AI narrative; recom 3. |
| 26 | BTCT | AVOID | 3.5 | Private placement dilution announced 7/9; -48% weekly drawdown but no fundamental floor. |
| 27 | PRSO | AVOID | 3.4 | $25M Roth stock purchase agreement 7/2 = pure dilution overhang despite big forecasts. |
| 28 | IPWR | AVOID | 3.2 | $75M shelf filed 7/10 + $30M direct offer just closed = active dilution; ps 2178 is broken. |
| 29 | CCB | AVOID | 3.0 | CFO departure 7/23 with stock trading lower; 1wk forecasts negative (-8.65/-18.26/-26.22%). |
| 30 | USBC | AVOID | 2.5 | 1d forecasts negative (-15.41/-56.6/-40.73%) contradict weekly; near_term=0; $0.32 price shell. |
Get AI top picks & forecasts on any stock
K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.
Create your free account →Already a member? Sign in · Join our Discord